NR4A1 and neoplasm: Even though the risk peaks occur at about the same time following primary cancer resection, regardless of tumour hormone receptor status, the overall risk level of early recurrence is much higher for patients bearing Estrogen Receptor (ER) negative (N) tumours than for those bearing ER positive (P) tumours.